Kraehenbuehl L, Weng CH, Eghbali S, et al. Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways. Nat Rev Clin Oncol. 2022;19:37–50. https://doi.org/10.1038/s41571-021-00552-7.

Article  CAS  PubMed  Google Scholar 

Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, Kramer J, Siegel RL. Cancer treatment and survivorship statistics. Cancer J Clin. 2022;72(5):409–36. https://doi.org/10.3322/caac.21731.

Article  Google Scholar 

Zhang X, Yang B, Ni Q, Chen X. Materials engineering strategies for cancer vaccine adjuvant development. Chem Soc Rev. 2023. https://doi.org/10.1039/D2CS00647B.

Article  PubMed  PubMed Central  Google Scholar 

Pulendran B, Arunachalam SP, O’Hagan DT. Emerging concepts in the science of vaccine adjuvants. Nat Rev Drug Discov. 2021;20:454–75. https://doi.org/10.1038/s41573-021-00163-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

M. Saxena, S. H. van der Burg, C. J. M. Melief and N. Bhardwaj. Nat Rev Cancer. 2021, 21; 360–378 647

Maslow JN. Vaccine development for emerging virulent infectious diseases. Vaccine. 2017;35(41):5437–43.

Article  PubMed  PubMed Central  Google Scholar 

Finn OJ. The dawn of vaccines for cancer prevention. Nat Rev Immunol. 2017;18(3):183–94.

Article  PubMed  Google Scholar 

Saxena M, van der Burg SH, Melief CJ, Bhardwaj N. Therapeutic cancer vaccines. Nat Rev Cancer. 2021;21(6):360–78.

Article  CAS  PubMed  Google Scholar 

Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature. 2011;480(7378):480–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng C, Tan P, Nie G, Zhu M. Biomimetic and bioinspired nano‐platforms for cancer vaccine development. In Exploration. 2023, p. 20210263.

Kenter GG, Welters MJP, Valentijn ARPM, Lowik MJG, Berends-van der Meer DMA, Vloon APG, et al. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. New Eng J Med. 2009;361(19):1838–47.

Article  CAS  PubMed  Google Scholar 

Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y. Sipuleucel-T immunotherapy for castration- resistant prostate cancer. N Engl J Med. 2010;363(5):411–22.

Article  CAS  PubMed  Google Scholar 

Neller MA, Alejandro Lopez J, Schmidt CW. Antigens for cancer immunotherapy. Semin Immunol. 2008;20(5):286–95.

Article  CAS  PubMed  Google Scholar 

Del Giudice G, Rappuoli R, Didierlaurent AM. Correlates of adjuvanticity: a review on adjuvants in licensed vaccines. Semin Immunol. 2018;39(14):14–21.

Article  PubMed  Google Scholar 

Lynn GM, Sedlik C, Baharom F, Zhu Y, Ramirez-Valdez RA, Coble VL, et al. Peptide– TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens. Nat Biotechnol. 2020;38(3):320–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van der Burg SH, Arens R, Ossendorp F, van Hall T, Melief CJM. Vaccines for established cancer: overcoming the challenges posed by immune evasion. Nat Rev Cancer. 2016;16(4):219–33.

Article  PubMed  Google Scholar 

Wang J, Zhu M, Nie G. Biomembrane-based nanostructures for cancer targeting and therapy: from synthetic liposomes to natural biomembranes and membrane-vesicles. Adv Drug Deliv Rev. 2021;178(113974): 113974.

Article  CAS  PubMed  Google Scholar 

Nie G, Zhu M, Zhao XL, Nie G. Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity. Adv Drug Delivery Rev. 2021;176(113889):113889–9.

Google Scholar 

Du G, Sun X. Current advances in sustained release microneedles. Pharm Fronts. 2020;02(01):11–22.

Article  Google Scholar 

Deng H, Song K, Zhao X, Li Y, Wang F, Zhang J, et al. Tumor microenvironment activated membrane fusogenic liposome with speedy antibody and doxorubicin delivery for synergistic treatment of metastatic tumors. ACS Appl Mater Interfaces. 2017;9(11):9315–26.

Article  CAS  PubMed  Google Scholar 

Sun L, Gao Y, Wang Y, Wei Q, Shi J, Chen N, et al. Guiding protein delivery into live cells using DNA-programmed membrane fusion. Chem Sci. 2018;9(27):5967–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dutta DK, Pulsipher A, Luo W, Mak H, Yousaf MN. Engineering cell surfaces via liposome fusion. Bioconjugate Chem. 2011;22(12):2423–33.

Article  CAS  Google Scholar 

Kunisawa J. Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development. Adv Drug Deliv Rev. 2001;52(3):177–86.

Article  CAS  PubMed  Google Scholar 

Zhang H, You X, Wang X, Cui L, Wang Z, Xu F, et al. Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling. Proceedings of the National Academy of Sciences of the United States of America. 2021; 118(6).

Luk BT, Zhang L. Cell membrane-camouflaged nanoparticles for drug delivery. J Control Release. 2015;220(600):600–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krishnan N, Kubiatowicz LJ, Holay M, Zhou J, Fang RH, Zhang L. Bacterial membrane vesicles for vaccine applications. Adv Drug Deliv Rev. 2022;185(114294): 114294.

Article  CAS  PubMed  Google Scholar 

Ma XY, Hill BD, Hoang T, Wen F. Virus-inspired strategies for cancer therapy. Sem Cancer Biol. 2021;86:1143.

Article  Google Scholar 

Zafar A, Arshad R, Ur.Rehman A, Ahmed N, Akhtar H. Recent developments in oral delivery of vaccines using nanocarriers. Vaccines. 2023;11(2):490.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marasini N, Skwarczynski M, Toth I. Oral delivery of nanoparticle-based vaccines. Expert Rev Vaccines. 2014;13:1361–76.

Article  CAS  PubMed  Google Scholar 

Taddio A, Ipp M, Thivakaran S, Jamal A, Parikh C, Smart S, Sovran J, Stephens D, Katz J. Survey of the prevalence of immunization noncompliance due to needle fears in children and adults. Vaccine. 2012;30:4807–12.

Article  PubMed  Google Scholar 

Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger JA. Vaccine hesitancy: an overview. Hum Vaccines Immunother. 2013;9:1763–73.

Article  Google Scholar 

Kremsner PG, Mann P, Kroidl A, Leroux-Roels I, Schindler C, Gabor JJ, Schunk M, Leroux-Roels G, Bosch JJ, Fendel R. Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2. Wien Klin Wochenschr. 2021;133:931–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dad HA, Gu TW, Zhu AQ, Huang LQ, Peng LH. Plant exosome-like nanovesicles: emerging therapeutics and drug delivery nanoplatforms. Mol Ther. 2021;29(1):13–31.

Article  CAS  PubMed  Google Scholar 

Zhuang X, Teng Y, Samykutty A, Mu J, Deng Z, Zhang L, Cao P, Rong Y, Yan J, Miller D, Zhang HG. Grapefruit-derived nanovectors delivering therapeutic miR17 through an intranasal route inhibit brain tumor progression. Mol Ther. 2016;24:96–105.

Article  CAS  PubMed  Google Scholar 

Song Y, Wu Y, Xu L, Jiang T, Tang C, Yin C. Caveolae- mediated endocytosis drives robusts iRNA delivery of polymeric nanoparticles to macrophages. ACS Nano. 2021;15:8267–82.

Article  CAS  PubMed  Google Scholar 

Fan W, Xia D, Zhu Q, Li X, He S, Zhu C, Guo S, Hovgaard L, Yang M, Gan Y. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oralinsulin delivery. Biomaterials. 2018;151:13–23.

Article  CAS  PubMed  Google Scholar 

Park J, Choi JU, Kim K, Byun Y. Bile acid transporter mediated endocytosis of oral bile acid conjugated nanocomplex. Biomaterials. 2017;147:145–54.

Article  CAS  PubMed  Google Scholar 

Ding Y, Li Z, Jaklenec A, Hu Q. Vaccine delivery systems toward lymph nodes. Adv Drug Deliv Rev. 2021;1(179): 113914.

Article  Google Scholar 

Jiang H, Wang Q, Sun X. Lymph node targeting strategies to improve vaccination efficacy. J Control Release. 2017;10(267):47–56.

Article  Google Scholar 

Tacken PJ, de Vries IJ, Torensma R, Figdor CG. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat Rev Immunol. 2007;7:790–802.

Article  CAS  PubMed  Google Scholar 

Zhang L, Wu S, Qin Y, Fan F, Zhang Z, Huang C, Ji W, Lu L, Wang C, Sun H, Leng X. Targeted codelivery of an antigen and dual agonists by hybrid nanoparticles for enhanced cancer immunotherapy. Nano Lett. 2019;19(7):4237–49.

Article  CAS  PubMed